| Literature DB >> 23195868 |
Yi-Ju Tseng1, Jung-Hsuan Wu, Xiao-Ou Ping, Hui-Chi Lin, Ying-Yu Chen, Rung-Ji Shang, Ming-Yuan Chen, Feipei Lai, Yee-Chun Chen.
Abstract
BACKGROUND: The emergence and spread of multidrug-resistant organisms (MDROs) are causing a global crisis. Combating antimicrobial resistance requires prevention of transmission of resistant organisms and improved use of antimicrobials.Entities:
Mesh:
Year: 2012 PMID: 23195868 PMCID: PMC3510772 DOI: 10.2196/jmir.2056
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1The system architecture of the Web-based multidrug-resistant organisms (MDRO) surveillance system.
Figure 2The software components of the application module consist of 7 subsystems.
Figure 3Equation 1.
Figure 4Equation 2.
Figure 5Flowchart of MDRO cluster analysis.
The definition and rationale of three counting criteria for multidrug-resistant organism surveillance and outbreak detection system.
| Criteria | Definition | Rationale |
| Germ criterion | The numbers of positive results in MDRO culture reports. | More MDROs isolated from an individual or a group of patients may represent the higher probability of spreading. |
| Patient criterion | The numbers of patients who have MDRO specimen reports. | The data present the disease burden at a given time. This data may help for resource allocation, such as the use of single room isolation versus cohorting of more than one patients with the same MDRO colonization/infection in the same room. |
| Incident patient criterion | The numbers of patients who were newly colonized or infected by MDRO if they did not have MDRO culture reports in the 30 days previous to the release of the current MDRO culture report. | The number of patients with newly acquired MDRO during their hospital stay. The higher incident of patients represents the poorer performance of infection control practice. More infection control personnel are likely required to remind, audit, or practice another intervention. |
Figure 6Control chart for visualization of the time series of the MDRO classification results in a defined patient population (eg, the whole hospital). This chart displays the numbers of vancomycin-resistant Enterococcus faecium isolates (germ criteria, y-axis) by week from March 9, 2008, to May 31, 2008 (x-axis).
Figure 7Bubble chart for visualization of the spatial distribution of MDRO clustering results. This chart display the spatial distribution of vancomycin-resistant Enterococcus faecium isolated from April 6, 2008, to April 26, 2008, and clustered with Euclidean distance equal to zero and single linkage.
Figure 8Line chart for visualization of the time trend of MDRO clustering results. This chart display the number of clustered vancomycin-resistant Enterococcus faecium isolates (germ criteria, y-axis), from April 6, 2008, to April 26, 2008, with Euclidean distance equal to zero and single linkage.
Figure 9Data description of suspicious and confirmed outbreaks due to vancomycin-resistant Enterococcus.
Figure 10The pyramid of vancomycin-resistant Enterococcus outbreaks identified, investigated, and confirmed, showing the concept of the integrated Web-based surveillance and outbreak detection system and infection control personnel expertise.
Performance in outbreak detection according to germ criterion and a upper control limit defined by 90% confidence interval, with and without clustering.
| Parameter | Without clustering | With clustering (d=0)g |
| Sensitivity (%)a | 90.0 (27/30) | 100 (30/30) |
| Specificity (%)b | 84.0 (630/750) | 86.7 (650/750) |
| PPV (%)c | 18.4 (27/147) | 23.1 (30/130) |
| NPV (%)d | 99.5 (630/633) | 100 (650/650) |
| AUCe (95% CIf) | 0.87 (0.81-0.94) | 0.93 (0.91-0.95) |
a Sensitivity = TP/(TP+FN) (where TP (true positive) is an outbreak correctly identified as an outbreak, and FN (false negative) is an outbreak wrongly identified as a non-outbreak).
b Specificity = TN/(TN+FP) (where TN (true negative) is a non-outbreak correctly identified as a non-outbreak, and FP (false positive) is a non-outbreak wrongly identified as an outbreak).
c Positive predictive value (PPV) = TP/(TP+FP) (variables defined above).
d Negative predictive value (NPV) = TN/(TN+FN) (variables defined above).
e AUC: area under receiver operating characteristic curve.
f CI: confidence interval.
g d: cutting Euclidean distance.
Stability of clustering with germ, patient, and incident patient criteria and a variety of cutting Euclidean distance.
| Criteria | Cutting distancea | APN | AD | ADM | FOM |
| Germ criterion | 0 | 0.00 | 0.12 | 0.12 | 0.18 |
| Patient criterion | 0 | 0.00 | 0.12 | 0.12 | 0.17 |
| 1 | 0.00 | 0.78 | 0.01 | 0.20 | |
| Incident patient criterion | 0 | 0.00 | 0.13 | 0.13 | 0.18 |
| 1 | 0.00 | 0.83 | 0.01 | 0.21 |
a d: cutting Euclidean distance.
b Average proportion of non-overlap (APN).
c Average distance (AD).
d Average distance between means (ADM).
e Figure of merit (FOM).
Performance in outbreak detection according to patient criterion and a variety of upper control limits defined by 1 standard deviation and 85% confidence interval, with and without clustering.
| Without clustering | With clustering (d=1)g | With clustering (d=0) | |||
| 1 standard deviation | 1 standard deviation | Upper 85% CI | |||
| Sensitivity (%)a | 86.7 (26/30) | 86.7 (26/30) | 90.0 (27/30) | ||
| Specificity (%)b | 83.5 (626/750) | 83.2 (624/750) | 83.6 (627/750) | ||
| PPV (%)c | 17.3 (26/150) | 17.1 (26/152) | 18.0 (27/150) | ||
| NPV (%)d | 99.4 (626/630) | 99.4 (624/628) | 99.5 (627/630) | ||
| AUCe (95% CIf) | 0.85 (0.78-0.92) | 0.85 (0.78-0.92) | 0.87 (0.80-0.93) |
a-g as shown in Table 2 footnotes.
Performance in outbreak detection according to incident patient criterion and a variety of upper control limits defined by 1 standard deviation and 90% confidence interval, with and without clustering.
| Without clustering | With clustering (d=1)g | With clustering (d=0) | |
| Upper 90% CI | Upper 90% CI | 1 standard deviation | |
| Sensitivity (%)a | 76.7 (23/30) | 76.7 (23/30) | 80.0 (24/30) |
| Specificity (%)b | 83.9 (629/750) | 83.9 (629/750) | 87.3 (655/750) |
| PPV (%)c | 16.0 (23/144) | 16.0 (23/144) | 20.2 (24/119) |
| NPV (%)d | 99.0 (629/636) | 99.0 (629/636) | 99.1 (655/661) |
| AUCe (95% CIf) | 0.80 (0.72-0.89) | 0.80 (0.72-0.89) | 0.84 (0.75-0.92) |
a-g as shown in Table 2 footnotes.